Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00041
Full Text
Open PDFAbstract
Available in full text
Date
February 4, 2019
Authors
Publisher
Frontiers Media SA